Other

Dataset Information

0

SNCA triplication disrupts proteostasis and extracellular architecture prior to neurodegeneration in human midbrain organoids [Ribo-seq]

ABSTRACT: Synucleinopathies, including Parkinson’s disease, are characterized by α-synuclein (SNCA) aggregation and progressive neurodegeneration, yet the early molecular events linking SNCA gene dosage to disrupted proteostasis remain poorly understood. Here, we used human midbrain organoids derived from induced pluripotent stem cells (iPSC) carrying an SNCA triplication (SNCA Trip) and the isogenic corrected line (SNCA Isog) to dissect early pathogenic mechanisms in a 3D human model of synucleinopathy. We combined immunohistochemistry, immunoblotting, tandem mass tag proteomics, bulk RNA sequencing, and ribosome profiling to systematically characterize molecular alterations in SNCA Trip organoids at day 50 (D50) and day 100 (D100) of maturation. SNCA Trip organoids exhibited increased α-synuclein accumulation, neuromelanin deposition, and activation of mTORC1 (p-rpS6), ERK1/2, AKT and p-eIF2α signalling pathways by D100. Proteomic and transcriptomic analyses revealed upregulation of cytoskeletal, synaptic, and axonal development pathways, alongside significant downregulation of extracellular matrix (ECM) components and upregulation of perineuronal net (PNN) genes. Ribosome profiling showed minimal global translational changes but uncovered selective translational buffering of neuronal and ECM-associated transcripts. Confocal imaging confirmed progressive disorganization of pericellular and interstitial ECM structures around neurons in SNCA Trip organoids. Our findings demonstrate that SNCA triplication induces early proteostatic disruption and extracellular matrix remodelling prior to neurodegeneration and suggest that altered gene expression and ECM homeostasis may contribute to disease initiation and progression. Targeting these early aberrant mechanisms may offer new therapeutic opportunities for synucleinopathies, such as Parkinson’s Disease.

ORGANISM(S): Homo sapiens

PROVIDER: GSE299914 | GEO | 2026/04/09

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics SNCA triplication disrupts proteostasis and extracellular architecture prior to neurodegeneration in human midbrain organoids [RNA-seq]
2026-04-09 | GSE299913 | GEO
Proteomics SNCA triplication disrupts proteostasis and extracellular architecture prior to neurodegeneration in human midbrain organoids
2026-04-06 | PXD063729 | Pride
Transcriptomics Single cell RNA sequencing analysis of midbrain organoids with SNCA gene triplication modeling key features of synuclienopathy
2021-11-02 | GSE186780 | GEO
Transcriptomics SNP data from genomic DNA from a subject, fibroblasts, iPSCs and neurons with four copies of SNCA, and genomic DNA from an unaffected first degree relative and equivalent cell lines
2011-09-14 | E-GEOD-28366 | biostudies-arrayexpress
Transcriptomics Expression data from Parkison's iPSCs with four copies of SNCA, and equivalent cell lines from an unaffected first degree relative
2011-09-14 | E-GEOD-30792 | biostudies-arrayexpress
Genomics SNP data from genomic DNA from a subject, fibroblasts, iPSCs and neurons with four copies of SNCA, and genomic DNA from an unaffected first degree relative and equivalent cell lines
2011-09-15 | GSE28366 | GEO
Transcriptomics Expression data from fibroblasts, iPSCs and neurons with four copies of SNCA, and equivalent cell lines from an unaffected first degree relative
2011-09-14 | E-GEOD-28365 | biostudies-arrayexpress
Transcriptomics Expression data from fibroblasts, iPSCs and neurons with four copies of SNCA, and equivalent cell lines from an unaffected first degree relative
2011-09-15 | GSE28365 | GEO
Transcriptomics Expression data from Parkinson's iPSCs with four copies of SNCA, and equivalent cell lines from an unaffected first degree relative
2011-09-15 | GSE30792 | GEO
Transcriptomics Synaptic vesicle endocytosis deficits underlie GBA-linked cognitive dysfunction in Parkinson’s disease and Dementia with Lewy bodies
2025-04-15 | GSE283187 | GEO